Literature DB >> 12975605

Chondrodysplasia of gene knockout mice for aggrecan and link protein.

Hideto Watanabe1, Yoshihiko Yamada.   

Abstract

The proteoglycan aggregate of the cartilage is composed of aggrecan, link protein, and hyaluronan and forms a unique gel-like moiety that provides resistance to compression in joints and a foundational cartilage structure critical for growth plate formation. Aggrecan, a large chondroitin sulfate proteoglycan, is one of the major structural macromolecules in cartilage and binds both hyaluronan and link protein through its N-terminal domain G1. Link protein, a small glycoprotein, is homologous to the G1 domain of aggrecan. Mouse cartilage matrix deficiency (cmd) is caused by a functional null mutation of the aggrecan gene and is characterized by perinatal lethal dwarfism and craniofacial abnormalities. Link protein knockout mice show chondrodysplasia similar to but milder than cmd mice, suggesting a supporting role of link protein for the aggregate structure. Analysis of these mice revealed that the proteoglycan aggregate plays an important role in cartilage development and maintenance of cartilage tissue and may provide a clue to the identification of human genetic disorders caused by mutations in these genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12975605     DOI: 10.1023/A:1025344332099

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  24 in total

1.  Identification of hyaluronan-binding domains of aggrecan.

Authors:  H Watanabe; S C Cheung; N Itano; K Kimata; Y Yamada
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration.

Authors:  D Kohda; C J Morton; A A Parkar; H Hatanaka; F M Inagaki; I D Campbell; A J Day
Journal:  Cell       Date:  1996-09-06       Impact factor: 41.582

3.  Mapping of a defined neurocan binding site to distinct domains of tenascin-C.

Authors:  U Rauch; A Clement; C Retzler; L Fröhlich; R Fässler; W Göhring; A Faissner
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.

Authors:  A Aspberg; S Adam; G Kostka; R Timpl; D Heinegård
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.

Authors:  B Lanske; A C Karaplis; K Lee; A Luz; A Vortkamp; A Pirro; M Karperien; L H Defize; C Ho; R C Mulligan; A B Abou-Samra; H Jüppner; G V Segre; H M Kronenberg
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

6.  Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage matrix deficiency) mouse.

Authors:  K Kimata; H J Barrach; K S Brown; J P Pennypacker
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

7.  Abnormal collagen fibrillogenesis in epiphyseal cartilage of CMD (cartilage matrix deficiency) mouse.

Authors:  M Kobayakawa; H Iwata; K S Brown; K Kimata
Journal:  Coll Relat Res       Date:  1985-03

8.  Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene.

Authors:  H Watanabe; K Kimata; S Line; D Strong; L Y Gao; C A Kozak; Y Yamada
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

9.  Exclusion of human proteoglycan link protein (CRTL1) and type II collagen (COL2A1) genes in pseudoachondroplasia.

Authors:  J T Hecht; S H Blanton; Y Wang; S P Daiger; W A Horton; C Rhodes; Y Yamada; C A Francomano
Journal:  Am J Med Genet       Date:  1992-11-01

10.  Disrupted expression of matrix genes in the growth plate of the mouse cartilage matrix deficiency (cmd) mutant.

Authors:  A W Wai; L J Ng; H Watanabe; Y Yamada; P P Tam; K S Cheah
Journal:  Dev Genet       Date:  1998
View more
  23 in total

Review 1.  The different roles of aggrecan interaction domains.

Authors:  Anders Aspberg
Journal:  J Histochem Cytochem       Date:  2012-09-26       Impact factor: 2.479

2.  Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations.

Authors:  Ola Nilsson; Michael H Guo; Nancy Dunbar; Jadranka Popovic; Daniel Flynn; Christina Jacobsen; Julian C Lui; Joel N Hirschhorn; Jeffrey Baron; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

3.  Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Authors:  Muneaki Ishijima; Nobuharu Suzuki; Kentaro Hozumi; Tomoya Matsunobu; Keisuke Kosaki; Haruka Kaneko; John R Hassell; Eri Arikawa-Hirasawa; Yoshihiko Yamada
Journal:  Matrix Biol       Date:  2012-03-07       Impact factor: 11.583

Review 4.  Short and tall stature: a new paradigm emerges.

Authors:  Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

5.  Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene.

Authors:  Jose Bernardo Quintos; Michael H Guo; Andrew Dauber
Journal:  J Pediatr Endocrinol Metab       Date:  2015-07       Impact factor: 1.634

6.  Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Authors:  Susan M Smith; John M Whitelock; Renato V Iozzo; Christopher B Little; James Melrose
Journal:  Histochem Cell Biol       Date:  2009-08-11       Impact factor: 4.304

7.  Detection of genes regulated by Lmx1b during limb dorsalization.

Authors:  Jennifer M Feenstra; Kohei Kanaya; Charmaine U Pira; Sarah E Hoffman; Richard J Eppey; Kerby C Oberg
Journal:  Dev Growth Differ       Date:  2012-03-15       Impact factor: 2.053

8.  Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker.

Authors:  Susan M Smith; Cindy Shu; James Melrose
Journal:  Histochem Cell Biol       Date:  2010-08-06       Impact factor: 4.304

9.  Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb.

Authors:  Kazu Matsumoto; Yingcui Li; Caroline Jakuba; Yoshinori Sugiyama; Tetsuya Sayo; Misako Okuno; Caroline N Dealy; Bryan P Toole; Junji Takeda; Yu Yamaguchi; Robert A Kosher
Journal:  Development       Date:  2009-08       Impact factor: 6.868

Review 10.  Are animal models useful for studying human disc disorders/degeneration?

Authors:  Mauro Alini; Stephen M Eisenstein; Keita Ito; Christopher Little; A Annette Kettler; Koichi Masuda; James Melrose; Jim Ralphs; Ian Stokes; Hans Joachim Wilke
Journal:  Eur Spine J       Date:  2007-07-14       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.